Episode 1246 • • 3:01:21 - 3:05:11
1246: 3X3
Moderna Vaccine, Press Release Data and Market Manipulation
Dr. William Hasseltine criticized Moderna on CNBC for publishing "premature and opaque" results of its vaccine trials via press release rather than through peer-reviewed data. He noted that only eight people were studied and that the announcement appeared designed to boost stock prices rather than inform public health. The segment highlights the potential for market manipulation when pharmaceutical companies release incomplete data during a pandemic.